To read the full story, subscribe or sign in.

TD2 and Rondaxe sign alliance to help emerging companies develop cancer therapeutics

Feb. 18, 2010

No Comments

BioWorld Science Other news to note Collaboration

Today's news in brief

BioWorld

BioWorld briefs for Oct. 31, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for October 31, 2024.

By the numbers: US leads charge of cell and gene therapies

BioWorld

U.S. biotechs and regulators ushered in the era of gene therapy in 2023, experts at Bio Japan said, but medical reform is needed to pave the way for the “year of...

Regulatory actions for Oct. 31, 2024

BioWorld

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...

Nanocube’s nanorobots to revolutionize cancer diagnosis, treatment

BioWorld MedTech

Nanocube Health Ltd. is developing accessible, low-cost nanorobots that could revolutionize diagnosis and treatment of hard-to-diagnose cancers, with pancreatic...

Upgrade your daily dose of biopharma and medtech news

TD2 and Rondaxe sign alliance to help emerging companies develop cancer therapeutics